Amy Hunckler, KPMG Strategy

Articles by Amy Hunckler, KPMG Strategy

Specialty drug market access reality check

ByBy Peter Gilmore,Amy Hunckler, KPMG Strategy

September 1st 2016

Ten payer pressures to act on now

Latest Updated Articles

Specialty drug market access reality check
September 1st 2016

Trending on Pharmaceutical Commerce

Why Pharma's Next AI Challenge Is Supervision, Not Adoption

Gregg Gorniak: What Changed in Five Years of DSCSA?

FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers

Why Your NDC-12 Roadmap Should Start Now

Using AI to Manage GDP-Compliant Supply Chains